AstraZeneca to Invest $2.5B in New Global R&D Center in Beijing: A Bold Leap into the Future of Pharma Innovation
In a groundbreaking move set to reshape the landscape of pharmaceutical research and development in Asia, AstraZeneca has announced a staggering $2.5 billion investment in Beijing over the next five years. This historic commitment will see the establishment of AstraZeneca’s sixth global strategic R&D center, positioned to spearhead early-stage research and clinical development with cutting-edge […]